Grant of Stock Option-Based Share Compensation to Directors and Executive Officers
First written in FY2018-Q2. 15 of 19 entries say "Advanced", first in FY2018. Latest entry: 2026-06-19.
15 other companies' latest entry also says "Advanced".
- 2026-06-19AdvancedGovernance
「The Company hereby announces that it has revised its executive compensation system as part of initiatives to enhance corporate value, as described below.」
The Company specified revisions to its executive compensation system, including a higher proportion of stock-based compensation, higher proportions and maximum award coefficients for TSR-linked restricted stock, the introduction of stock-based compensation for outside directors and others, and the addition of ROE and ROIC as performance metrics. - FY2026AdvancedAnnual report
「The actual growth rate under the company's market-capitalization condition used to calculate the final number of shares allocated under the market-capitalization-based restricted shares whose evaluation period ended during the fiscal year was 205%.」
For the former market-capitalization-based restricted shares, the company disclosed a market-capitalization condition growth rate of 205% following the end of the 3-year evaluation period. - 2026-04-20RestatedGovernance
「The Company grants restricted stock and TSR-linked restricted stock to directors other than outside directors and executive officers in order to share the benefits and risks of share price movements with shareholders and further strengthen their incentives to contribute to higher share prices and corporate value.」
The Company reconfirmed its compensation structure using restricted stock and TSR-linked restricted stock, as well as its policy of linking compensation to shareholder value. - FY2025AdvancedAnnual report
「The actual growth rate under the company's market-capitalization condition used to calculate the final number of shares allocated under the market-capitalization-based restricted shares whose evaluation period ended during the fiscal year was 299%.」
For the former market-capitalization-based restricted shares, the 3-year evaluation period ended and the company disclosed an actual market-capitalization condition growth rate of 299%. - FY2025-H1AdvancedAnnual report
「Through the issuance of new shares in exchange for monetary compensation claims granted as market-capitalization-based restricted share compensation, the total number of issued shares increased by 81,954 shares, capital stock by ¥112 million and capital surplus by ¥112 million, dated 29 August 2024.」
Under the restricted share compensation plan, the company issued 81,954 market-capitalization-based shares on 29 August 2024. This updates the implementation results of the scheme's transition from the former stock option plan to share-based compensation. - FY2023ReframedAnnual report
「From fiscal 2023, the company revised its performance-linked compensation. Under the previous system, performance in the preceding fiscal year served as the performance measure. Under the revised design, the amount based on performance for the fiscal year corresponding to the period of service will be paid in a lump sum as a performance-linked bonus after the end of that fiscal year, aligning the period of service with the performance evaluation period and increasing incentives during the period of service.」
After moving from a system centered on stock options to restricted shares, the company restructured its compensation framework from fiscal 2023 to combine performance-linked bonuses with TSR-linked restricted shares. - FY2022AdvancedAnnual report
「During the consolidated fiscal year, the number of issued shares increased by 534,597 shares dated 21 July 2021 through the issuance of new shares in exchange for monetary compensation claims granted as restricted share compensation.」
The company generally abolished its former stock option plan and actually issued 534,597 restricted shares as compensation. - FY2022-Q1AdvancedAnnual report
「The stock acquisition rights issued during the first quarter accounting period were as follows: stock options (share-based compensation stock options) based on a resolution of the Board of Directors meeting held on 23 March 2021: number of stock acquisition rights, 712; class, terms and number of underlying shares, common shares, 71,200 shares. Stock options (market-capitalization-based share-based compensation stock options) based on a resolution of the Board of Directors meeting held on 23 March 2021: number of stock acquisition rights, 280; class, terms and number of underlying shares, common shares, 28,000 shares.」
The company issued ordinary and market-capitalization-based share-based compensation stock options. It also issued 534,597 shares dated 21 July 2021 as restricted share compensation. - FY2021ReframedAnnual report
「In connection with the introduction of this plan, the company resolved to abolish the provisions governing the amount of compensation and other payments relating to stock acquisition rights as stock options for eligible directors and not to issue any further stock acquisition rights as stock options based on those provisions, except for rights already granted.」
The company reorganized its compensation scheme, moving from the existing share-based compensation stock options to restricted shares and market-capitalization-based restricted shares. - FY2021-Q2AdvancedAnnual report
「Stock options (share-based compensation stock options) based on a resolution of the Board of Directors meeting held on 19 June 2020: categories and number of grantees, company directors excluding outside directors, 6; executive officers of the company who do not concurrently serve as directors, 25; persons who served as directors through 19 June 2020, 1; number of stock acquisition rights, 5,210; class, terms and number of underlying shares, common shares, 521,000 shares. Stock options (market-capitalization-based share-based compensation stock options) based on a resolution of the Board of Directors meeting held on 19 June 2020: number of stock acquisition rights, 4,091; class, terms and number of underlying shares, common shares, 409,100 shares.」
Based on the resolution of 19 June 2020, the company issued stock options representing 521,000 shares under the ordinary plan and 409,100 shares under the market-capitalization-based plan. - FY2021-Q1AdvancedAnnual report
「Stock options (share-based compensation stock options) based on a resolution of the Board of Directors meeting held on 25 March 2020: categories and number of grantees, executive officers of the company who do not concurrently serve as directors, 4; number of stock acquisition rights, 1,591; class, terms and number of underlying shares, common shares, 159,100 shares.」
The company issued ordinary share-based compensation stock options representing 159,100 shares to 4 executive officers who do not concurrently serve as directors. It also issued market-capitalization-based options representing 357 rights and 35,700 shares, which became exercisable from 25 April 2023. - FY2020AdvancedAnnual report
「During the consolidated fiscal year, the weighted average fair values of stock options issued under the company's stock option plan at the respective measurement dates were ¥741 and ¥641.」
The company granted ordinary share-based compensation stock options representing 753,400 shares and market-capitalization-based options representing 299,900 shares. - FY2020-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows: stock options (share-based compensation stock options) based on a resolution of the Board of Directors meeting held on 21 June 2019: number of stock acquisition rights, 7,368; class, terms and number of underlying shares, common shares, 736,800 shares. Stock options (market-capitalization-based share-based compensation stock options) based on a resolution of the Board of Directors meeting held on 21 June 2019: number of stock acquisition rights, 2,999; class, terms and number of underlying shares, common shares, 299,900 shares.」
Based on the resolution of 21 June 2019, the company issued ordinary share-based compensation stock options representing 736,800 shares and market-capitalization-based options representing 299,900 shares. - FY2020-Q1AdvancedAnnual report
「Stock options (share-based compensation stock options) based on a resolution of the Board of Directors meeting held on 27 March 2019 Categories and number of grantees Executive officers of the company who do not concurrently serve as directors 1 Number of stock acquisition rights * 166 Class, terms and number of shares underlying the stock acquisition rights * Common shares 16,600 shares」
Based on the resolution of 27 March 2019, the company granted 166 share-based compensation stock options representing 16,600 shares to 1 executive officer who does not concurrently serve as a director. - FY2019AdvancedAnnual report
「In addition, from fiscal 2019, with the aim of increasing incentives to raise market capitalization over the longer term, the company will introduce new market-capitalization-based share-based compensation stock options. These will be allocated as stock acquisition rights in an amount equivalent to up to 1.5 times 10% of base compensation, in addition to current compensation. The exercise commencement date will be 3 years after allocation, and the options will be exercisable only if, after 3 years, the company's market capitalization exceeds its market capitalization at the allocation date and the growth rate of its market-capitalization condition is at least the growth rate of TOPIX (Tokyo Stock Price Index).」
In addition to the existing share-based compensation stock options, the company introduced a scheme based on 10% of base compensation, with a maximum amount of 1.5 times that amount, subject to exercise conditions based on market capitalization after 3 years and comparison with TOPIX. - FY2019-Q2AdvancedAnnual report
「Stock options (share-based compensation stock options) based on a resolution of the Board of Directors meeting held on 22 June 2018 Resolution date 22 June 2018 Categories and number of grantees Company directors, excluding outside directors 6 Executive officers of the company who do not concurrently serve as directors 22 Number of stock acquisition rights * 4,645 Class, terms and number of shares underlying the stock acquisition rights * Common shares 464,500 shares (Note) 1」
Based on the resolution of 22 June 2018, the company issued 4,645 share-based compensation stock options representing 464,500 shares to 6 directors excluding outside directors and 22 executive officers. - FY2019-Q1AdvancedAnnual report
「Stock options (share-based compensation stock options) based on a resolution of the Board of Directors meeting held on 27 March 2018 Categories and number of grantees Executive officers of the company who do not concurrently serve as directors 6 Number of stock acquisition rights * 1,761 Class, terms and number of shares underlying the stock acquisition rights * Common shares 176,100 shares (Note) 1」
Based on the resolution of 27 March 2018, the company issued 1,761 share-based compensation stock options representing 176,100 shares to 6 executive officers who do not concurrently serve as directors. - FY2018AdvancedAnnual report
「Rights granted 532,300 1 Unexercised balance at period-end 1,004,700 1」
The company granted stock options representing 532,300 shares during the fiscal year, and the unexercised balance at period-end was 1,004,700 shares. - FY2018-Q2First statedAnnual report
「The stock acquisition rights issued during the second quarter accounting period were as follows: stock options (share-based compensation stock options) based on a resolution of the Board of Directors meeting held on 23 June 2017.」
Based on a resolution of the Board of Directors, the company issued 5,101 stock acquisition rights, representing 510,100 underlying shares, as share-based compensation stock options.